Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 60,328 | 85,475 | 47,141 | 161,394 | N/A |
| Marketable Securities | 606,639 | 175,707 | 262,900 | 144,768 | N/A |
| Receivables | 35,495 | 17,659 | 13,415 | 9,846 | N/A |
| Inventories | 9,696 | 4,806 | 3,604 | 4,266 | N/A |
| Other current assets | 17,941 | 12,449 | 9,362 | 11,748 | 0 |
| TOTAL | $730,099 | $296,096 | $336,422 | $332,022 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 22,546 | 19,600 | 10,646 | 8,396 | N/A |
| Intangibles | 6,185 | 5,983 | 0 | 0 | 0 |
| Other Non-Current Assets | 54,196 | 5,608 | 6,914 | 6,308 | 0 |
| TOTAL | $82,927 | $31,191 | $17,560 | $14,704 | $N/A |
| Total Assets | $813,026 | $327,287 | $353,982 | $346,726 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,340 | 16,516 | 10,832 | 10,869 | 0 |
| Accrued Expenses | 55,276 | 26,976 | 13,667 | 9,512 | N/A |
| Other current liabilities | 278 | 599 | N/A | N/A | N/A |
| TOTAL | $71,794 | $44,286 | $29,968 | $33,783 | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 589 | 109 | 4,883 | 12,474 | N/A |
| Other Non-Current Liabilities | 408,350 | 4,873 | 13,543 | 11,911 | 0 |
| TOTAL | $409,488 | $6,303 | $13,589 | $17,410 | $N/A |
| Total Liabilities | $481,282 | $50,589 | $43,557 | $51,193 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 651,810 | 643,588 | 605,190 | N/A | N/A |
| Common Shares | 814 | 802 | 756 | 740 | N/A |
| Retained earnings | -287,166 | -322,367 | -222,367 | -220,455 | N/A |
| Other shareholders' equity | 10,612 | 6,986 | 5,014 | -4,043 | 0 |
| TOTAL | $331,744 | $276,698 | $310,426 | $295,533 | $N/A |
| Total Liabilities And Equity | $813,026 | $327,287 | $353,983 | $346,726 | $0 |